Evaluation Of The Efficacy Of The Australian Mammographic Screening Program
Funder
National Health and Medical Research Council
Funding Amount
$504,096.00
Summary
BreastScreen Australia uses interim measures such as participation, small cancer detection and interval cancer rates to monitor the impact of the program on mortality. Using BreastScreen Victoria as a case study, we will estimate the direct impact of the program on mortality for screened women, addressing Cancer Australia's priority of 'Improving screening program outcomes to ensure that patients can be identified and treated appropriately and ensuring that screening services are effective'.
Genome-wide SNP Analysis Of Fibroblasts Juxtaposed Or Distant From Epithelial Breast And Ovarian Tumours
Funder
National Health and Medical Research Council
Funding Amount
$401,763.00
Summary
In the past it was believed that the driving factor in the process of cancer devlopment was the cancer tissue itself. More recently however, it has become clear that the process is far more complex and that many aspects of human biology can profoundly influence both an individuals presiposition to cancer and the severity of disease. Many laboratories, including our own, have shown that gene mutations frequently occur in cancer tissue but recent studies have suggested that the apparently normal t ....In the past it was believed that the driving factor in the process of cancer devlopment was the cancer tissue itself. More recently however, it has become clear that the process is far more complex and that many aspects of human biology can profoundly influence both an individuals presiposition to cancer and the severity of disease. Many laboratories, including our own, have shown that gene mutations frequently occur in cancer tissue but recent studies have suggested that the apparently normal tissue surrounding the cancer (often referred to stroma) may also contain mutations. This so called 'cancer associated stroma'(CAS) is also thought to harbour genetic mutations and some studies have shown that without these mutations the cancer cannot survive. At present we have only had glimpses of the genetic alterations that may occur in CAS and there is an urgent need to fully understand the interplay between CAS and frankly cancerous tissue. Our laboratory will utilise high density, genome-wide screening technologies to search for novel mutations in CAS from breast and ovarian cancers. A complete understanding of the role stroma plays in cancer development is likely to lead to novel ways of treating and preventing cancer. Consequently, the identification of the full repertoire of stroma-derived cancer promoting genes is emerging as one of the most important areas in cancer research. The identification of these genes could lead to the development of novel diagnostic markers for use in cancer detection, diagnosis and-or prognosis.Read moreRead less
Skin cancers, including melanoma, present a significant health, social and economic burden in Australia. Despite the rising incidence of melanoma, the most deadly form of skin cancer, there is currently no national or population-based screening program available. The aim of this CRE is to identify how novel skin imaging technologies can be integrated into the pathway to improve early detection, and ultimately reduce the health and economic burden caused by melanoma skin cancer.
The Assessment Of Clinical And Molecular Adjunctive Tools For The Early Detection Of Oral Mucosal Neoplasia
Funder
National Health and Medical Research Council
Funding Amount
$454,383.00
Summary
It is anticipated that this research will make a significant contribution to our understanding of the natural development of oral cancer and will thus have a direct benefit to patients. The proposed research will enable high quality genetic analysis of individual mutations of relevance to oral cancer via a rapid, reliable, economic, and sensitive screening assay for the assessment of a large number of suspicious oral mucosal lesions.
Effectiveness And Cost-effectiveness Of Systematic Screening For Lynch Syndrome (LS) In Australia
Funder
National Health and Medical Research Council
Funding Amount
$485,762.00
Summary
Lynch syndrome (LS) is an inherited condition that puts people at an increased risk of developing a range of cancers. We will use a detailed simulation model to evaluate the potential health benefits of testing new cases of colorectal, endometrial and ovarian cancers for LS, and whether this would be cost-effective. The aim is to identify LS-related cancer cases, so family members can be offered LS testing, and individuals found to have LS can be offered close observation/preventative surgery.
FAST-Australia: A Phase II Study Of Family History Screening For Chronic Disease Prevention In Primary Care.
Funder
National Health and Medical Research Council
Funding Amount
$343,429.00
Summary
Risk of developing certain cancers, heart disease and diabetes is increased by having an affected family member. People found to be at risk can be offered ways to prevent or detect these diseases early through lifestyle advice or disease screening. This project will develop and evaluate a family history questionnaire in preparation for a trial of family history screening and its impact on disease prevention.
Reducing Colorectal Cancer Burden In Young Adults: Precision Prevention And Early Detection
Funder
National Health and Medical Research Council
Funding Amount
$1,449,800.00
Summary
Bowel cancer rate in young adults before age 50 is increasing worldwide including Australia. Since it is impossible to screen everyone, it is critical to identify who is likely to develop the disease, to optimise screening. Using the world's largest resource for young-onset bowel cancer, I will conduct studies to generate high-quality evidence to inform how to best prevent bowel cancer in young adults and translate into the policy and practice, to reduce colorectal cancer burden in young adults.
PSA Testing: A Population-based Longitudinal Study Of Decision Making, Psychological Effects And Patterns Of Care
Funder
National Health and Medical Research Council
Funding Amount
$576,977.00
Summary
Prostate cancer is the most commonly diagnosed cancer in Australian men and the second most common cancer- related cause of death. Since being introduced into Australia in 1988 the Prostate Specific Antigen (PSA) blood test has been widely adopted as a method for detecting early-stage asymptomatic prostate cancer. However there is controversy about the potential benefits and harms of testing for prostate cancer. Little has been documented in Australia about the information men receive when consi ....Prostate cancer is the most commonly diagnosed cancer in Australian men and the second most common cancer- related cause of death. Since being introduced into Australia in 1988 the Prostate Specific Antigen (PSA) blood test has been widely adopted as a method for detecting early-stage asymptomatic prostate cancer. However there is controversy about the potential benefits and harms of testing for prostate cancer. Little has been documented in Australia about the information men receive when considering a PSA test, what happens to men after having an abnormal PSA test and the consequences of PSA testing (including physical and psychological effects). The aim of this study is to interview a representative community sample of men aged 50 to 84 years and resident in NSW to describe: (1) the decision-making process regarding PSA testing; (2) the psychological consequences of men's PSA testing experiences; and (3) patterns of care for men who have had an abnormal PSA test. The main outcomes from this study will include substantial information on the experiences of men regarding patterns of PSA participation (frequency of, and reasons for, testing), the clinical management of men who have had an abnormal PSA test, the psychological effects of PSA testing (both positive and negative) and how decisions about testing are being made. This will provide important information to assist GPs, urologists and Australian men make decisions about PSA testing. It will highlight areas of need regarding the information required by men for informed decision-making and the support they require when undergoing PSA testing to ensure positive psychological outcomes.Read moreRead less
Translating Risk Models To Improve Prevention And Early Diagnosis Of Cancer In Primary Care
Funder
National Health and Medical Research Council
Funding Amount
$479,882.00
Summary
Primary care plays a key role in prevention and early diagnosis of cancer. This fellowship will apply evidence about cancer risk to help GPs provide tailored advice to patients about preventing common cancers. It will also use new risk tools to assess people with symptoms suggestive of cancer to support earlier diagnosis. The research extends to studies relating to how people interpret symptoms and ways of promoting earlier presentation to the GP in patients who are at higher risk of cancer.